Peppermint and lemon scents put to the test against chemo nausea
NCT ID NCT04560114
First seen Aug 17, 2026 ยท Last updated Aug 17, 2026
Summary
This phase 2 trial tests whether inhaling a blend of peppermint and lemon essential oils can reduce nausea and vomiting in people receiving their first chemotherapy for a solid tumor. Participants will inhale the oils four times daily and whenever nausea strikes, with symptoms tracked over the first days after treatment. The study aims to measure how well this natural approach works as a supportive care option.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Inhaled blend of peppermint and lemon essential oils
- What this could lead to
- If effective, this could offer a safe, natural option to help reduce nausea and vomiting during chemotherapy, improving quality of life for cancer patients.
- What could go wrong
- This is an early-phase study without a placebo comparison, so results may be inconclusive. Effectiveness is not yet proven, and individual responses to aromatherapy can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AROMATHERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Francois Baclesse
Caen, 14000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may spare cancer patients unneeded iron infusions
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a Tumor's DNA guide better cancer care for kids?
- Could essential oils tame chemo nausea? a new trial puts aromatherapy to the test
- Can a new PET tracer reveal a key cancer target?
- Can a smart drug home in on Hard-to-Treat cancers?